MétaCan
Menu
Back to cohort
Record W3021818590 · doi:10.1136/bmjebm-2019-pod.85

73 Is magnetic resonance imaging in prostate cancer a possible avenue for reducing overdiagnosis?

2019· article· en· W3021818590 on OpenAlexaff
Geneviève Asselin, Sylvain L’Espérance, Alice Nourissat, Marc Rhainds

Bibliographic record

VenueOral Presentations · 2019
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsUniversité Laval
Fundersnot available
KeywordsMedicineOverdiagnosisProstate cancerConfidence intervalProstateMagnetic resonance imagingRadiologyBiopsyRandomized controlled trialCancerInternal medicine

Abstract

fetched live from OpenAlex

Background Transrectal ultrasonography (TRUS)-guided biopsies is the conventional diagnosis pathway in prostate cancer (PCa). However, this practice results of a high proportion of men diagnosed with clinically insignificant tumor, and eventually overtreatment. Scientific data suggest that multiparametric magnetic resonance imaging (mpMRI) improves detection of clinically significant prostate cancer (csPCa) over TRUS-guided biopsies. We aimed to determine the diagnostic performance of mpMRI for the detection of csPCa and to estimate the reduction of unnecessary prostate biopsy (PBx). Method Literature searches were conducted in several indexed databases and grey literature between January 2008 and January 2019 to retrieve studies on mpMRI in diagnostic of csPCa. Two reviewers independently performed selection, quality assessment and data extraction. Eligible studies: 1) PBx-naïve patient or patient with previous negative PBx, 2) mpMRI performed with T2 and at least two functional MRI techniques, 3) PI-RADS scale for image assessment, 4) PBx as reference test. Sensibility (Se), specificity (Sp), negative predictive value (NPV), positive predictive value (PPV) and negative likelihood ratio (LR-) were estimated based on a positivity threshold of PI-RADS ≥ 3. A meta-analyze were performed using bivariate hierarchical models to estimate mean value and 95% confidence interval (95%CI) of Se, Sp, NPV, PPV and LR-. Sub-group analyses included: csPCA prevalence quartiles, PBx status and number of core PBx. Proportion of patient with unnecessary PBx was estimated from the rate of negative mpMRI results (PI-RADS ≤ 2). Results Forty-two original studies (1 RCT, 26 prospective and 15 retrospective studies) were included. Median csPCa prevalence (range) was 31% (13–55%) in all studies, 40% (21–47%) for PBx-naïve groups and 29% (13–55%) for previous negative PBx groups. Median value (range) of Se and Sp were 94% (62–100%) and 45% (2–79%), respectively. Median rates (range) of NPV (range) and PPV (range) were respectively 92% (33–100%) and 45% (18–88%) in all studies. In PBx-naïve groups and previous negative PBx groups, NPV (range) were 89% (33–100%) and 93% (50–100%), respectively. Median value (range) of mpMRI false-negative and false-positive rates was 7% (0–38%) and 55% (3–98%) respectively. Median rate of mpMRI negative results (PI-RADS ≤ 2) in all studies was 31% (range: 1–83%). Bivariate analysis results (95%CI) showed that mean Se, Sp, NPV and LR- were 92% [90–94%], 44% [36–52%], 92% [90–94%] and 0.17 (0.14–0.22), respectively. Sub-group analysis suggest small variations in NPV value according to the PBx status and the number of PBx, but a significant inverse relationship with csPCA prevalence (p = 0.01). Conclusions The results indicates a very low probability to find csPCa when mpMRI result is negative (PI-RADS ≤ 2) in PBx-naïve groups and previous negative PBx groups. Assuming that patients with PI-RADS ≤ 2 do not undergo PBx, we estimate that nearly one-third of men under diagnosis testing for prostate cancer suspicion could avoid unnecessary TRUS-guided PBx and negative adverse conséquences.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.036
metaresearch head score (Gemma)0.101
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.036
Threshold uncertainty score0.189

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0360.101
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0050.008
Bibliometrics0.0050.007
Science and technology studies0.0000.001
Scholarly communication0.0030.003
Open science0.0020.001
Research integrity0.0030.001
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.338
Teacher spread0.317 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueOral PresentationsSame topicProstate Cancer Diagnosis and TreatmentFrench-language works237,207